Miriam N. Lango, MD, FACS

Miriam Lango, MD, FACS

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111


Professor, Department of Surgical Oncology

Medical Director, Speech Pathology Service

Professor, Department of Otolaryngology 

Director for the Head and Neck Oncologic Surgery Fellowship

Head and Neck Cancer TRDG Member

Thyroid and Endocrine Cancer TRDG Member

Treatment Focus

  • Salivary gland tumors; paragangliomas; sinonasal malignancies and skull base tumors; neck masses
  • Voice and swallowing disorders
  • Transoral robotic surgery and transoral laser microsurgery
  • Organ preservation larynx surgery
  • Thyroid and parathyroid surgery
  • Anterior skull base and sinus surgery
  • Head and neck reconstructive surgery

Research Program

Key Awards

Philadelphia Magazine Top Docs 2018

Treatment Philosophy

I joined the department of surgical oncology at Fox Chase Cancer Center in 2004 as a head and neck surgeon, as well as an ear, nose and throat specialist. In my practice, I have a special interest in tumors located in the upper aerodigestive tract, thyroid, skull base and sinonasal tract. My particular area of treatment expertise is minimally-invasive and transoral surgery.

It is an exciting time to work in my field. Traditionally, cancers of the head and neck (mouth, tongue, larynx and pharynx) required radical surgery followed by radiation. Surgery frequently robbed patients of the ability to speak intelligibly, swallow or eat solid food. Today, many more options are available. I believe the goal of treatment is to cure cancer while preserving as much quality of life as possible. Technological advances in surgery have made this possible for many patients.

Today, surgeons can safely remove deeply seated tumors with little collateral damage to normal tissues by using minimally-invasive surgical techniques. Since not every tumor is appropriately treated using minimally-invasive approaches, it is important for each patient to undergo a comprehensive evaluation before starting treatment. For some patients, surgery may not be a good option. Radiation with or without chemotherapy may be more effective or provide a better quality of life in the long term.

Because all patients and tumors are different, decision-making can be complex. Typically, a patient who is evaluated at Fox Chase Cancer Center will see physicians from several specialties including surgical oncology, radiation oncology and medical oncology. I believe that this type of multispecialty evaluation is important in determining the best treatment for each patient. Armed with state-of-the-art information, our patients can make informed decisions about their care.

I believe that patient quality of life has been a relatively neglected area of study. Novel treatment approaches have the potential to diminish treatment-related side effects. I am currently the principal investigator of a clinical trial to measure swallowing function and quality of life in head and neck cancer patients. I hope that what we learn will be used to help guide treatment recommendations for our patients.

Follow on Twitter: @FCCCSurgOnc

Education and Training

Educational Background

  • Fellow, Head and Neck Oncologic and Microvascular Reconstructive Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
  • Resident, Otolaryngology/Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
  • New York University School of Medicine, New York, NY, 1996


  • American Board of Otolaryngology/Head and Neck Surgery


  • American Academy of Otolaryngology
  • American Association of Endocrine Surgeons
  • American College of Surgeons
  • American Head and Neck Society
  • American Society of Clinical Oncology
  • American Thyroid Association
  • Eastern Cooperative Oncology Study Group

Honors & Awards

  • Philadelphia magazine Top Doctors, 2012-18
  • America's Top Doctors®2016-17
Patient Stories

Scott Parker

Head & Neck Cancer

Scott Parker

Head & Neck Cancer

When Scott Parker was 45, he began losing his voice. He was soon diagnosed with laryngeal cancer by an ear, nose, and throat specialist. Then he sought treatment at Fox Chase Cancer Center because he knew of the Center's name and reputation. Scott had a long road ahead; he underwent radiation and had a laryngectomy, followed by reconstructive surgery, which was a success. He worked with Fox Chase's speech pathology department after surgery, which he now only needs on an as-needed basis. "I now come to Fox Chase for any medical needs I might have that they offer," Scott said. "If they offer it at Fox Chase, this is where I come. I’m so confident in the people here."

Jeff Lambert


Jeff Lambert


I was 34 years old when I was diagnosed with melanoma. Today I am cancer free and enjoying life with my wife, Kathleen, and our daughter, Zoey.

Charlie Osborne

Head & Neck Cancer

Charlie Osborne

Head & Neck Cancer

Charlie Osborne quit smoking over 20 years ago because he noticed people getting annoyed with smokers — and was no longer allowed to smoke at work. He also knew it was a health hazard. By quitting the habit, Charlie thought his chances of developing cancer had been diminished. Unfortunately, that was not the case.

In early 2005, at the age of 52, Charlie experienced problems swallowing and had a blocked windpipe. He had trouble sleeping and began losing weight.

Stephen Meier

Head & Neck Cancer

Stephen Meier

Head & Neck Cancer

"I’m the kind of person who isn’t prone to panic. Panic just causes confusion. So, when what began as soreness on the right side of my throat turned out to be cancer, I remained calm and figured somebody can fix it."

Paul Reitano

Head & Neck Cancer

Paul Reitano

Head & Neck Cancer

Paul Reitano was an active 45-year-old male with two careers, who was looking to start a family with his wife. After getting an initial diagnosis of squamous cell carcinoma from an ENT at a local hospital, Paul and his wife decided to seek a second opinion from Dr. Miriam Lango at Fox Chase Cancer Center. After Paul learned he actually had HPV tonsil cancer, not squamous cell carcinoma, he sought radiation therapy, chemotherapy, and surgery at Fox Chase with the help of Dr. Longo and Dr. Thomas Galloway. Today he is cancer free. "Not a day goes by since then that I am not grateful that I chose Fox Chase and Dr. Lango for my care," Paul said. "There was a real comfort in seeing her, and I trusted her completely. I will always love Miriam Lango as my oncologist and my friend. The decision to be treated by her saved my life and allowed me to give life to a little girl."


Research Profile

Research Program

Research Interests

  • Thyroid cancer
  • Head and neck cancer
  • Melanoma
  • Quality of Life/Outcomes research

Selected Publications

Tamaki A, Miles BA, Lango M, Kowalski L, Zender CA. AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer. Head & neck. 2018;40(1):170-181.

Lango MN, Handorf E, Arjmand E. The geographic distribution of the otolaryngology workforce in the United States. The Laryngoscope. 2017;127(1):95-101.

Lango MN, Galloway TJ, Mehra R, et al. Impact of baseline patient-reported dysphagia on acute gastrostomy placement in patients with head and neck squamous cell carcinoma undergoing definitive radiation. Head & neck. 2016;38 Suppl 1:E1318-1324.

Cracchiolo J, Ridge JA, Egleston B, Lango M. Practice arrangement and Medicare physician payment in otolaryngology. Otolaryngol Head Neck Surg. 2015 Jun;152(6):979-87.

Aaron H, Azadarmaki R, Lango MN. Unilateral Vocal Cord Motion Impairment After 1 Dose of Vincristine: Case Report and Literature Review. Am J Ther. 2015 May 27.[Epub ahead of print] PubMed PMID: 25738569.

Arrangoiz R, Galloway TJ, Papavasiliou P, Ridge JA, Lango MN. Metastatic cervical carcinoma from an unknown primary: literature review. Ear Nose Throat J. 2014 Apr-May;93(4-5):E1-10. Review.

Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, Mehra R, Ebersole B, Moran K, Ridge JA. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer. 2014 Mar 15;120(6):840-7.

Tejani MA, Galloway TJ, Lango M, Ridge JA, von Mehren M. Head and neck sarcomas: a comprehensive cancer center experience. Cancers (Basel). 2013 Jul 15;5(3):890-900.

Azadarmaki R, Lango MN. Malignant transformation of respiratory papillomatosis in a solid-organ transplant patient: case report and literature review. Ann Otol Rhinol Laryngol. 2013 Jul;122(7):457-60. Review.

Lango M, Flieder D, Arrangoiz R, et al. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.Thyroid : official journal of the American Thyroid Association. 2013;23(9):1099-1105.

Galloway TJ, Lango MN, Burtness B, Mehra R, Ruth K, Ridge JA. Unilateral neck therapy in the human papillomavirus ERA: accepted regional spread patterns. Head Neck. 2013 Feb;35(2):160-4.

Andrews G, Lango M, Cohen R, Feigenberg S, Burtness B, Mehra R, Ahmed S, Nicolaou N, Gaughan J, Ridge JA. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience. Head Neck. 2011 Oct;33(10):1433-40.

Lango MN, Topham NS, Perlis CS, Flieder DB, Weaver MW, Turaka A, Patel SA, Ridge JA. Surgery in the multimodality treatment of sinonasal malignancies. Curr Probl Cancer. 2010 Sep-Oct;34(5):304-21. Review.

Lango MN, Egleston B, Ende K, Feigenberg S, D'Ambrosio DJ, Cohen RB, Ahmad S, Nicolaou N, Ridge JA. Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation. Head Neck. 2010 Mar;32(3):341-7.

Lango M, Ridge JA. Lymph node dissection for thyroid cancer. Duh Q-Y, Clark OH, Kebebew E, editors. In: Atlas of Endocrine Surgical Techniques. Philadelphia: Saunders; 2010. p. 72-85. 

Lango MN, Andrews GA, Ahmad S, Feigenberg S, Tuluc M, Gaughan J, Ridge JA. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head Neck. 2009 Mar;31(3):328-37.

Lango MN, Dyer KF, Lui VW, Gooding WE, Gubish C, Siegfried JM, Grandis JR. Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck. J Natl Cancer Inst. 2002 Mar 6;94(5):375-83.

Additional Publications




Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.


4.9 / 5.0


  • 4.9
  • 4.9
  • 5.0
  • 5.0
  • 4.8


  • 5.0
    August 02, 2018
    Overall good experience with Dr. Lango and entire staff.
  • 4.0
    July 24, 2018
  • 5.0
    July 17, 2018
    Bad - all follow-up could not be scheduled on same day - (staff did try - they made EXTRA effort since I travel far - I didn't even have to ask. Staff tried on their own!
  • 5.0
    July 05, 2018
    I came to Dr. Lango for a second opinion and even though we have just begun the testing process I have faith that she can help me get thru this situation much better than a dr in my area
  • 4.5
    June 19, 2018
    Wait time bad.
  • 5.0
    June 04, 2018
    Very pleased with office & provider.
  • 5.0
    May 31, 2018
    I have full trust and confidence in Dr. Miriam Lango and appreciate her giving me details of tumors and of operation and possible effects as well as followup care.
  • 5.0
    May 30, 2018
    This Care-Provider has following my condition through three (3) operations and radiation treatment since 2010 and I have been cancer free since the last operation.
  • 5.0
    April 26, 2018
  • 5.0
    March 22, 2018
    Dr Lango is very warm, friendly, professional person.
  • 5.0
    March 13, 2018
    Dr. Lango is a terrific dr. She has an excellent staff. I was lucky to have her as my dr. I can see why she is considered a top doc.
  • 5.0
    January 25, 2018
    My Doctor was outstanding and gave me complete confidence in my upcoming surgery .

Connect with Fox Chase